This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ferrara F, Ravasio R.Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma. Clinical Drug Investigation 28: 55-65, No. 1, 2008
Rights and permissions
About this article
Cite this article
R-CHOP economically dominant over CHOP in DLBCL. Pharmacoecon. Outcomes News 544, 5 (2008). https://doi.org/10.2165/00151234-200805440-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805440-00008